Skip to main content
NCBI home page
Mediators of Inflammation logoLink to Mediators of Inflammation
. 1994;3(1):23–25. doi: 10.1155/S0962935194000049

PAF and Haematopoiesis. I. 5-Fluoro-Uracil Induces PAF Production in Haematopoietic Organs of Rats

Y Denizot 1,✉, V Praloran 1
PMCID: PMC2367019  PMID: 18472919

Abstract

Haematopoietic organs of rats were examined for the presence of platelet-activating factor (PAF) and acetylhydrolase before and after treatment with 5-fluoro-uracil (5-FU) (200 mg/kg) a chemotherapeutic compound with apoptotic effects. PAF was reported in thymus, spleen and femoral bone marrow of rats with or without 5-FU. Although acetylhydrolase activity in organs was not affected by 5-FU treatment, elevated levels of PAF were observed in thymus and spleen. For the first time PAF is reported in haematopoietic organs of rats, strengthening in vitro data suggesting its role in the apoptotic processes in thymus, in the modulation of the immune response, and in the regulation of haematopoiesis.

Full Text

The Full Text of this article is available as a PDF (315.8 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bussolino F., Foa R., Malavasi F., Ferrando M. L., Camussi G. Release of platelet-activating factor (PAF)-like material from human lymphoid cell lines. Exp Hematol. 1984 Oct;12(9):688–693. [PubMed] [Google Scholar]
  2. Camussi G., Aglietta M., Coda R., Bussolino F., Piacibello W., Tetta C. Release of platelet-activating factor (PAF) and histamine. II. The cellular origin of human PAF: monocytes, polymorphonuclear neutrophils and basophils. Immunology. 1981 Feb;42(2):191–199. [PMC free article] [PubMed] [Google Scholar]
  3. Caplan M. S., Sun X. M., Hsueh W. Hypoxia causes ischemic bowel necrosis in rats: the role of platelet-activating factor (PAF-acether). Gastroenterology. 1990 Oct;99(4):979–986. doi: 10.1016/0016-5085(90)90616-9. [DOI] [PubMed] [Google Scholar]
  4. Denizot Y., Chaussade S., Nathan N., Colombel J. F., Bossant M. J., Cherouki N., Benveniste J., Couturier D. PAF-acether and acetylhydrolase in stool of patients with Crohn's disease. Dig Dis Sci. 1992 Mar;37(3):432–437. doi: 10.1007/BF01307739. [DOI] [PubMed] [Google Scholar]
  5. Deryckx S., de Waal Malefyt R., Gauchat J. F., Vivier E., Thomas Y., de Vries J. E. Immunoregulatory functions of paf-acether. VIII. Inhibition of IL-4-induced human IgE synthesis in vitro. J Immunol. 1992 Mar 1;148(5):1465–1470. [PubMed] [Google Scholar]
  6. Eliakim R., Karmeli F., Razin E., Rachmilewitz D. Role of platelet-activating factor in ulcerative colitis. Enhanced production during active disease and inhibition by sulfasalazine and prednisolone. Gastroenterology. 1988 Nov;95(5):1167–1172. doi: 10.1016/0016-5085(88)90346-0. [DOI] [PubMed] [Google Scholar]
  7. Foa R., Bussolino F., Ferrando M. L., Guarini A., Tetta C., Mazzone R., Gugliotta L., Camussi G. Release of platelet-activating factor in human leukemia. Cancer Res. 1985 Sep;45(9):4483–4485. [PubMed] [Google Scholar]
  8. Hodgson G. S., Bradley T. R. Properties of haematopoietic stem cells surviving 5-fluorouracil treatment: evidence for a pre-CFU-S cell? Nature. 1979 Oct 4;281(5730):381–382. doi: 10.1038/281381a0. [DOI] [PubMed] [Google Scholar]
  9. Jouvin-Marche E., Ninio E., Beaurain G., Tence M., Niaudet P., Benveniste J. Biosynthesis of Paf-acether (platelet-activating factor). VII. Precursors of Paf-acether and acetyl-transferase activity in human leukocytes. J Immunol. 1984 Aug;133(2):892–898. [PubMed] [Google Scholar]
  10. Kato T., Kudo I., Hayashi H., Onozaki K., Inoue K. Augmentation of DNA synthesis in guinea pig bone marrow cells by platelet-activating factor (PAF). Biochem Biophys Res Commun. 1988 Dec 15;157(2):563–568. doi: 10.1016/s0006-291x(88)80286-9. [DOI] [PubMed] [Google Scholar]
  11. Leprince C., Vivier E., Treton D., Galanaud P., Benveniste J., Richard Y., Thomas Y. Immunoregulatory functions of paf-acether. VI. Dual effect on human B cell proliferation. Lipids. 1991 Dec;26(12):1204–1208. doi: 10.1007/BF02536532. [DOI] [PubMed] [Google Scholar]
  12. Miwa M., Miyake T., Yamanaka T., Sugatani J., Suzuki Y., Sakata S., Araki Y., Matsumoto M. Characterization of serum platelet-activating factor (PAF) acetylhydrolase. Correlation between deficiency of serum PAF acetylhydrolase and respiratory symptoms in asthmatic children. J Clin Invest. 1988 Dec;82(6):1983–1991. doi: 10.1172/JCI113818. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Prescott S. M., Zimmerman G. A., McIntyre T. M. Platelet-activating factor. J Biol Chem. 1990 Oct 15;265(29):17381–17384. [PubMed] [Google Scholar]
  14. Rola-Pleszczynski M., Pignol B., Pouliot C., Braquet P. Inhibition of human lymphocyte proliferation and interleukin 2 production by platelet activating factor (PAF-acether): reversal by a specific antagonist, BN 52021. Biochem Biophys Res Commun. 1987 Feb 13;142(3):754–760. doi: 10.1016/0006-291x(87)91478-1. [DOI] [PubMed] [Google Scholar]
  15. Saito H., Hayakawa T., Mita H., Akiyama K., Shida T. PAF-induced eosinophilic and basophilic differentiation in human hematopoietic precursor cells. J Lipid Mediat. 1992 Jun-Jul;5(2):135–137. [PubMed] [Google Scholar]
  16. Salem P., Denizot Y., Pitton C., Dulioust A., Bossant M. J., Benveniste J., Thomas Y. Presence of paf-acether in human thymus. FEBS Lett. 1989 Oct 23;257(1):49–51. doi: 10.1016/0014-5793(89)81783-1. [DOI] [PubMed] [Google Scholar]
  17. Sen S., D'Incalci M. Apoptosis. Biochemical events and relevance to cancer chemotherapy. FEBS Lett. 1992 Jul 27;307(1):122–127. doi: 10.1016/0014-5793(92)80914-3. [DOI] [PubMed] [Google Scholar]
  18. Stafforini D. M., McIntyre T. M., Carter M. E., Prescott S. M. Human plasma platelet-activating factor acetylhydrolase. Association with lipoprotein particles and role in the degradation of platelet-activating factor. J Biol Chem. 1987 Mar 25;262(9):4215–4222. [PubMed] [Google Scholar]
  19. Vivier E., Deryckx S., Wang J. L., Valentin H., Peronne C., de Vries J. E., Bernard A., Benveniste J., Thomas Y. Immunoregulatory functions of paf-acether. VI. Inhibition of T cell activation via CD3 and potentiation of T cell activation via CD2. Int Immunol. 1990;2(6):545–553. doi: 10.1093/intimm/2.6.545. [DOI] [PubMed] [Google Scholar]
  20. el Azzouzi B., Jurgens P., Benveniste J., Thomas Y. Immunoregulatory functions of paf-acether. IX. Modulation of apoptosis in an immature T cell line. Biochem Biophys Res Commun. 1993 Jan 29;190(2):320–324. doi: 10.1006/bbrc.1993.1050. [DOI] [PubMed] [Google Scholar]

Articles from Mediators of Inflammation are provided here courtesy of Wiley

RESOURCES